X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.accesswire.com/737215/NLS-Pharmaceutics-Announces-Completion-of-Open-Label-Extension-Study-with-Quilience-Mazindol-ER-for-the-Treatment-of-Narcolepsy
https://www.accesswire.com/736231/NLS-Pharmaceutics-Announces-New-In-Vitro-Data-Reconfirming-QuiliencesR-Mazindol-ER-Unique-Dual-Mechanism-of-Action-Involving-Significant-Orexin-2-Receptor-Activity
https://www.accesswire.com/729650/NLS-Pharmaceutics-Announces-Notice-of-Allowance-for-US-Patent-Covering-Mazindol-for-Opioid-Dependence-and-Substance-Use-Disorder
https://www.accesswire.com/724117/NLS-Pharmaceutics-Provides-Open-Label-Extension-Study-Update-for-QuilienceR-Mazindol-ER-in-the-Treatment-ofNarcolepsy
https://www.accesswire.com/723437/US-FDA-Grants-Orphan-Drug-Designation-ODD-for-QuilienceR-Mazindol-ER-for-the-Treatment-of-Idiopathic-Hypersomnia-IH
https://www.fiercepharma.com/pharma/novartis-former-weight-loss-med-sanorex-center-nj-pharma-chiefs-guilty-plea
http://www.fiercebiotech.com/biotech/swiss-biotech-nls-touts-positive-adhd-data-plots-late-stage-tests
http://www.prnewswire.com/news-releases/mazindol-granted-orphan-drug-designation-in-the-us--europe-for-treatment-of-narcolepsy-300296065.html
https://www.pharmacompass.com/pdf/news/dr-reddys-generic-palonosetron-hydrochloride-approved-in-us-1461414788.pdf
Market Place
Share 
